• Media type: E-Article
  • Title: Plasma 11b,17a,21-Trihydroxypregn-4-ene-3,20-dione as Blood Biomarker Assay. A controlled study
  • Contributor: Bechir, Edwin Sever; Tuculina, Mihaela Jana; Carsote, Mara; Dascalu, Ionela Teodora; Raescu, Mihaela; Nicola, Andreea; Cumpata, Cristian Niky
  • Published: Revista de Chimie SRL, 2019
  • Published in: Revista de Chimie, 70 (2019) 10, Seite 3515-3517
  • Language: English
  • DOI: 10.37358/rc.19.10.7587
  • ISSN: 0034-7752; 2668-8212
  • Keywords: General Chemistry ; Materials Science (miscellaneous) ; Materials Chemistry ; Process Chemistry and Technology ; General Engineering ; General Biochemistry, Genetics and Molecular Biology ; General Medicine ; General Pharmacology, Toxicology and Pharmaceutics
  • Origination:
  • Footnote:
  • Description: 11b,17a,21-Trihydroxypregn-4-ene-3,20-dione or cortisol (C21H30O5) represents the product of adrenal glands and in humans its assessment is a useful tool for evaluation of glucocorticoid axes. Our purpose is to evaluate the profile of morning plasma cortisol/ACTH/ionogram in menopausal women with non-functioning adrenal tumours. A controlled study of 193 menopausal women found that BMI is statistically significant higher versus control in subjects with unilateral, respective bilateral adrenal non-secretor tumours. Baseline C21H30O5 is similar between the groups while ACTH is decreased when compare with control group indicating a potential persistent cortisol tumour-related exposure. Glycated haemoglobin A1c is increased in group with single adrenal mass (versus control) while serum sodium is higher in group with double adrenal masses (versus control).
  • Access State: Open Access